CD248 and hepatocellular carcinoma: The clinical studies associate activity of HSC with HCC recurrence and poor prognosis [94,95,102,214].While some evidence suggests tumour-suppressive roles, such as endosialin-mediated inhibition of HCC proliferation, the predominant view underscores HSCs as facilitators of HCC progression.